MRKR · Marker Therapeutics, Inc. · Executive Compensation
$1.06
+0.01 (+0.95%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding our ability to continue as a going concern. Our condensed consolidated financial statements have been prepared on a going concern basis, which implies that we will continue to realize our assets and discharge our liabilities in the normal course of business. Our financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$19.17M
Shares
16.67M
Volume · Oct 5
73.49K
Avg daily vol (3M)
69.91K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Juan Vera | President and Chief Executive Officer | $741,190 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Juan Vera | President and Chief Executive Officer | $400,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Peter Hoang | Former President and Chief Executive Officer | $582,394 |
| Juan Vera | President and Chief Executive Officer | $581,923 |
| Michael Loiacono | former Chief Accounting Officer | $566,515 |
| Mythili Koneru | our Former Chief Medical Officer | $220,146 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Former Chief | Financial Officer | $929,170 |
| Mythili Koneru | our Former Chief Medical Officer | $632,382 |
| Juan Vera | President and Chief Executive Officer | $581,923 |
| Peter Hoang | Former President and Chief Executive Officer | $556,170 |
| Michael Loiacono | former Chief Accounting Officer | $479,161 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Peter Hoang | Former President and Chief Executive Officer | $1,619,032 |
| Former Chief | Financial Officer | $948,291 |
| Anthony Kim | Chief Financial Officer | $948,291 |
| Mythili Koneru | Former Chief Medical Officer | $901,538 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Peter Hoang | President and Chief Executive Officer | $1,374,082 |
| Anthony Kim | Chief Financial Officer | $829,306 |
| Mythili Koneru | Chief Medical Officer | $782,200 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Mythili Koneru | Chief Medical Officer | $1,843,763 |
| Peter Hoang | President and Chief Executive Officer | $451,665 |
| Anthony Kim | Chief Financial Officer | $431,523 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kathryn Penkus Corzo | Board of Directors | Appointed | 2025-11-05 |
| John Wilson | Director | Resigned | 2025-01-30 |
| Juan Vera | Principal Financial and Accounting Officer | Appointed | 2023-11-20 |
| Eliot M. Lurier | Interim Chief Financial Officer and Principal Financial and Accounting Officer | Terminated | 2023-11-20 |
| Eliot M. Lurier | Interim Chief Financial Officer | Appointed | 2023-07-03 |
| Michael Loiacono | Chief Accounting Officer | Terminated | 2023-07-03 |
| Peter Hoang | member of the Company's Board of Directors | Resigned | 2023-05-01 |
| Peter Hoang | President and Chief Executive Officer | Resigned | 2023-05-01 |
| Mythili Koneru | Chief Medical Officer | Resigned | 2023-03-16 |
| Anthony Kim | Chief Financial Officer | Terminated | 2022-09-27 |